XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study

ID Number 08-0656

Principal Investigator(s)
Samin K Sharma

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


This is a prospective, open-label, multi-center, observational, single arm registry designed to evaluate XIENCE V EECSS continued safety and effectiveness on subjects for clinical use (after FDA approval).  Only XIENCE V EECSS stents are received during procedure (stent placement for blockages in blood vessels).

Contact Information
Kameswari Vallabhajosyula
(212) 241-5696

Recruiting Patients: No